Abrdn World Healthcare Fund (NYSE:THW) Declares Monthly Dividend of $0.12

Abrdn World Healthcare Fund (NYSE:THW) declared a monthly dividend on Monday, January 12th. Investors of record on Friday, January 23rd will be paid a dividend of 0.1167 per share on Friday, January 30th. This represents a c) dividend on an annualized basis and a yield of 10.9%. The ex-dividend date is Friday, January 23rd.

Abrdn World Healthcare Fund Stock Performance

Shares of THW stock traded down $0.04 during mid-day trading on Tuesday, reaching $12.79. 239,553 shares of the company’s stock traded hands, compared to its average volume of 187,457. Abrdn World Healthcare Fund has a 12 month low of $9.80 and a 12 month high of $13.19. The company’s 50-day moving average price is $12.67 and its 200-day moving average price is $12.02.

Institutional Trading of Abrdn World Healthcare Fund

Institutional investors and hedge funds have recently bought and sold shares of the stock. Newbridge Financial Services Group Inc. purchased a new position in Abrdn World Healthcare Fund during the second quarter worth $31,000. Advisory Services Network LLC purchased a new position in Abrdn World Healthcare Fund during the 3rd quarter valued at $43,000. Ameriflex Group Inc. bought a new position in Abrdn World Healthcare Fund in the 3rd quarter valued at $79,000. B. Riley Wealth Advisors Inc. purchased a new stake in Abrdn World Healthcare Fund in the second quarter worth $113,000. Finally, Integrity Alliance LLC. bought a new stake in shares of Abrdn World Healthcare Fund during the first quarter worth $131,000.

About Abrdn World Healthcare Fund

Abrdn World Healthcare Fund (NYSE: THW) is a closed-end investment company that provides investors with diversified exposure to the global healthcare sector. Listed on the New York Stock Exchange, the fund seeks to deliver long-term capital appreciation by investing primarily in equity securities of companies engaged in pharmaceuticals, biotechnology, medical devices, healthcare services and related industries. Managed by the global healthcare equity team at Abrdn plc, the fund leverages the firm’s deep sector expertise and research capabilities to identify innovative businesses and established market leaders in both developed and emerging markets.

The fund’s portfolio spans a broad range of healthcare subsectors, including drug developers, medical equipment manufacturers, health insurers and providers of diagnostics and digital health solutions.